Filtered By:
Drug: Rituxan
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 5036 results found since Jan 2013.
Association of giant cell hepatitis and autoimmune hemolytic anemia in infancy
Orv Hetil. 2023 Sep 10;164(36):1432-1436. doi: 10.1556/650.2023.32848. Print 2023 Sep 10.ABSTRACTGiant cell hepatitis associated with autoimmune hemolytic anemia (GCH-AIHA) is a rare disorder with unfavorable prognosis, affecting infants and young children. The mortality rate is high, complications of acute liver failure, sepsis, or liver transplantation can be responsible for fatal outcomes. An 18-month-old child who was diagnosed previously with autoimmune hemolytic anemia, developed acute hepatitis and acute liver failure concomitant to the relapse of the disease. GCH-AIHA is characterized by Coombs positive hemolytic a...
Source: Orvosi Hetilap - September 11, 2023 Category: General Medicine Authors: Katalin Csernus Alexandra T észás G ábor Ottóffy Antal Dezs őfi-Gottl Andr ás Tárnok Source Type: research
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
Int J Hematol. 2023 Sep 10. doi: 10.1007/s12185-023-03657-0. Online ahead of print.ABSTRACTThrombotic thrombocytopenic purpura (TTP) can rapidly become a life-threatening condition, and the importance of its appropriate diagnosis and treatment cannot be overstated. Until recently, TTP has mainly been diagnosed by clinical findings such as thrombocytopenia and hemolytic anemia. In addition to these clinical findings, however, reduced activity of a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13) below 10% has become internationally accepted as a diagnostic criterion for TTP. TTP is classif...
Source: International Journal of Hematology - September 9, 2023 Category: Hematology Authors: Masanori Matsumoto Yoshitaka Miyakawa Koichi Kokame Yasunori Ueda Hideo Wada Satoshi Higasa Hideo Yagi Yoshiyuki Ogawa Kazuya Sakai Toshiyuki Miyata Eriko Morishita Yoshihiro Fujimura For TTP group of Blood Coagulation Abnormalities Research Study Team, R Source Type: research
Nine-year Follow-up of Lenalidomide Plus Rituximab as Initial Treatment for Mantle Cell Lymphoma
We report 9-year follow up of a multi-center phase 2 study of lenalidomide plus rituximab (LR) as initial treatment of MCL. The LR doublet is used as induction and maintenance until progression, with optional discontinuation after 3 years. We previously reported an overall response rate in evaluable patients of 92%, with 64% achieving a complete response. At a median follow up of 103 months, 17 (47%) of 36 evaluable patients remain in remission. The 9-year progression-free survival (PFS) and overall survival (OS) were 51% and 66%, respectively. During maintenance, hematologic adverse events (AEs) included asymptomatic grad...
Source: Adv Data - September 8, 2023 Category: Epidemiology Authors: Samuel Yamshon Gui Chen Caitlin Gribbin Paul Christos Bijal D Shah Stephen J Schuster Sonali M Smith Jakub Svoboda Richard R Furman John P Leonard Peter Martin Jia Ruan Source Type: research
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology
DISCUSSION: The panel achieved broad consensus on issues related to how to treat children with newly diagnosed ITP, providing a comprehensive review of all relevant clinical aspects.PMID:37677093 | DOI:10.2450/BloodTransfus.501
Source: Blood Transfusion - September 7, 2023 Category: Hematology Authors: Giovanna Russo Emilia Parodi Piero Farruggia Lucia D Notarangelo Silverio Perrotta Maddalena Casale Simone Cesaro Giovanni Del Borrello Giovanni C Del Vecchio Fiorina Giona Chiara Gorio Saverio Ladogana Giuseppe Lassandro Antonio Marzollo Karolina Maslak Source Type: research
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era
CONCLUSION: RT reduced LRD and improved the long-term net survival in early-stage DLBCL in the rituximab era. Further prospective studies are warranted to assess the specific patient population that would benefit the most from consolidative RT in early-stage DLBCL.PMID:37678622 | DOI:10.1016/j.radonc.2023.109902
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - September 7, 2023 Category: Radiology Authors: Xin Wang Xin Liu Qiu-Zi Zhong Tao Wu Yun-Peng Wu Yong Yang Bo Chen Hao Jing Yuan Tang Jing Jin Yue-Ping Liu Yong-Wen Song Hui Fang Ning-Ning Lu Ning Li Yi-Rui Zhai Wen-Wen Zhang Shu-Lian Wang Fan Chen Shu-Nan Qi Ye-Xiong Li Source Type: research
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology
DISCUSSION: The panel achieved broad consensus on issues related to how to treat children with newly diagnosed ITP, providing a comprehensive review of all relevant clinical aspects.PMID:37677093 | DOI:10.2450/BloodTransfus.501
Source: Blood Transfusion - September 7, 2023 Category: Hematology Authors: Giovanna Russo Emilia Parodi Piero Farruggia Lucia D Notarangelo Silverio Perrotta Maddalena Casale Simone Cesaro Giovanni Del Borrello Giovanni C Del Vecchio Fiorina Giona Chiara Gorio Saverio Ladogana Giuseppe Lassandro Antonio Marzollo Karolina Maslak Source Type: research
Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children
CONCLUSIONS: These results identified low-dose obinituzumab as a promising treatment option in children with steroid-dependent or frequently relapsing nephrotic syndrome, including those resistant to rituximab. The tolerance profile of obinutuzumab appears similar to that of rituximab, but hemogram and immunoglobulin levels should be monitored.PMID:37678236 | DOI:10.2215/CJN.0000000000000288
Source: Clinical Journal of the American Society of Nephrology : CJASN - September 7, 2023 Category: Urology & Nephrology Authors: Claire Dossier St éphanie Bonneric Veronique Baudouin Theresa Kwon Benjamin Prim Alexandra Cambier Anne Couderc Christelle Moreau Georges Deschenes Julien Hogan Source Type: research
